Coco Kou
Director of Finance/CFO at QHY GROUP
Coco Kou active positions
| Companies | Position | Start | End |
|---|---|---|---|
| QHY GROUP | Director of Finance/CFO | - | - |
| Comptroller/Controller/Auditor | - | - | |
| FOUR LEAF ACQUISITION CORPORATION | Director of Finance/CFO | 01/01/2022 | - |
Career history of Coco Kou
Former positions of Coco Kou
| Companies | Position | Start | End |
|---|---|---|---|
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Director of Finance/CFO | 01/01/2019 | 01/01/2021 |
Salion Food Condiment Co., Ltd.
 Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Director of Finance/CFO | 01/01/2017 | 01/01/2018 |
Training of Coco Kou
| Peking University | Graduate Degree |
| University of Hong Kong | Masters Business Admin |
| London Business School | Masters Business Admin |
| Columbia Business School | Masters Business Admin |
Statistics
International
| China | 4 |
| United States | 4 |
| Hong Kong | 2 |
Operational
| Director of Finance/CFO | 4 |
| Masters Business Admin | 3 |
| Comptroller/Controller/Auditor | 1 |
Sectoral
| Consumer Services | 5 |
| Industrial Services | 2 |
| Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| QHY GROUP | Industrial Services |
| FOUR LEAF ACQUISITION CORPORATION | Finance |
| Private companies | 2 |
|---|---|
Salion Food Condiment Co., Ltd.
Salion Food Condiment Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Salion Food Condiment Co., Ltd. engages in the manufacture of compound condiment products in Northern China. It operates through the following geographical segments: Mainland China, Singapore, Korea, Russia, Europe, and Others. The company was founded on August 23, 2016 and is headquartered in Beijing, China. | Consumer Non-Durables |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Coco Kou
- Experience
